Phase II Pilot Study of Fluconazole for Histoplasmosis, Blastomycosis, and Sporotrichosis

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 1991

Conditions

HistoplasmosisSporotrichosisBlastomycosis

Interventions

DRUG

fluconazole

All Listed Sponsors

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

collaborator

University of Alabama at Birmingham

OTHER

lead

National Center for Research Resources (NCRR)

NIH

NCT00004808 - Phase II Pilot Study of Fluconazole for Histoplasmosis, Blastomycosis, and Sporotrichosis | Biotech Hunter | Biotech Hunter